PIK3CG and cancer: Surprisingly, the so-called vascular normalization also enhances delivery of chemotherapy and responsiveness to radiotherapy, suggesting PI3K inhibitors as enhancers in cancer treatment (Fokas et al., 2012; Kim et al., 2017; Qayum et al., 2012).